Skip to main content

Rebuy Monetize Powered by Fluent Accelerates Merchant Growth as Partnership Scales Across Shopify

Fluent to Attend Rebuy Momentum Innovation Summit NYC on October 21 NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading provider of commerce media solutions, and Rebuy Engine, the leading ecommerce personalization platform for Shopify brands, today shared an update on the continued success of their strategic partnership, Rebuy Monetize powered by Fluent, which launched in May 2025 (originally as Rebuy Ads powered by Fluent). Rebuy and Fluent will showcase new opportunities for merchants at Rebuy Momentum Innovation Summit NYC on October 21, 2025. Accelerating Adoption and Revenue Rebuy Monetize powered by Fluent delivers personalized, non-competing offers that complement each brand’s experience, turning every checkout into an opportunity to delight customers and drive measurable incremental revenue....

Continue reading

Climb Global Solutions Sets Third Quarter 2025 Conference Call for October 30, 2025 at 8:30 a.m. ET

EATONTOWN, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) — {{DATELINECITY_DATE_GLOBENEWSWIRE_BUG}}Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, will host a conference call on Thursday, October 30, 2025 at 8:30 a.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2025. The Company’s results will be reported in a press release prior to the call. Climb’s management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing CLMB@elevate-ir.com. Date: Thursday, October 30, 2025Time: 8:30 a.m. Eastern timeToll-free dial-in number: (800) 445-7795International...

Continue reading

Cannabix Technologies Delivers BreathLogix Alcohol Screening Device to Oilfield Transportation Services Company

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report the delivery of its BreathLogix technology to an oil and gas transportation services company located in northern Alberta, Canada. The BreathLogix system is designed for rapid, unmanned testing and is tailored for industries where safety is critical, including mining, oil and gas, industrial operations, trucking, warehousing, and maritime sectors. This adoption underscores Cannabix’s commitment to providing innovative solutions that help reduce risk and promote a culture of safety.Figure 1. BreathLogix Alcohol device available with contactless and straw modes for rapid workplace pre-accessalcohol...

Continue reading

AmpliTech Group To Attend The 2025 MAXIM Growth Summit

HAUPPAUGE, N.Y., Oct. 16, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer and manufacturer of advanced signal-processing components for satellite, Public and Private 5G, and other communications networks, including complete 5G/6G systems, and a global distributor of IC packaging solutions, today announced its participation in the upcoming 2025 Maxim Growth Summit, taking place from October 22nd to 23rd at The Hard Rock Hotel NYC. AmpliTech Group will be meeting with institutional investors in a one-on-one format, and senior Maxim analysts during the event. This prestigious event brings together industry leaders, innovators, and premier institutions to explore the latest trends and advancements across several industries. Keynote speakers include Larry Kudlow (Broadcaster, Fox News) and Christopher...

Continue reading

Cloudastructure, Inc. Announces Up to $5 Million Share Repurchase Program to Enhance Shareholder Value

Action Underscores Board Confidence Following Triple-Digit Sales Growth and Expanding Market Demand for AI Security Solutions PALO ALTO, CA, Oct. 16, 2025 (GLOBE NEWSWIRE) — Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”), a recognized leader in AI Surveillance and Remote Guarding, today announced that its Board of Directors (the “Board”) authorized a share repurchase program under which the Company may repurchase up to $5 million of its outstanding shares of common stock in the open market, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The Company’s decision to repurchase its shares, as well as the timing of such repurchases, will depend on a variety of factors that include ongoing assessments...

Continue reading

Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace

Odyssey Medical Devices, Inc., a subsidiary of Odyssey Health Inc., to acquire exclusive global marketing and distribution rights for the BreastCheck® LAS VEGAS, Oct. 16, 2025 (GLOBE NEWSWIRE) — Odyssey Health, Inc. (OTCQB: ODYY), a medical device company with a focus in life-saving medical solutions today announced that the company has signed a sub-licensing agreement for exclusive, worldwide rights to the BreastCheck®, a non-invasive test for breast abnormalities. The definitive agreement, managed through its subsidiary Odyssey Medical Devices, Inc., is subject to certain closing conditions. The BreastCheck® test can be done at home and takes just 15 minutes. The results are immediate and BreastCheck® has been proven to be a reliable guide in the first stage identification of potential breast abnormalities. While BreastCheck®...

Continue reading

Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer

Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experience VANCOUVER, British Columbia and BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced the appointment of Tucker Kelly as Chief Financial Officer (CFO) and member of the Xenon senior executive team. Mr. Kelly is a proven executive who brings extensive strategic and commercial finance expertise, both in the U.S. and internationally, that will help the Company prepare for the anticipated commercialization of its lead candidate, azetukalner. Azetukalner is currently being studied broadly in three Phase...

Continue reading

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System Company Completes the Recruitment of its Commercial Leadership Team as it Remains On Track to Commence the Launch of The LIBERTY® SystemDuring Q4 of This Year HINGHAM, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and distributer of the innovative LIBERTY® Endovascular Robotic System, today announced that it will be exhibiting the LIBERTY® System at the upcoming Symposium on Clinical Interventional Oncology annual meeting (CIO), being held in Miami, FL on October 17-19. The annual symposium presents practical education on the latest treatments in the rapidly expanding field of interventional oncology and represents the first medical meeting...

Continue reading

AMD to Participate in Upcoming Investor Conferences

SANTA CLARA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) announced today that company executives will participate in the following events for the financial community:Dr. Lisa Su, chair and chief executive officer, will present at UBS’s 2025 Global Technology and AI Conference on Wednesday, Dec. 3, 2025. Jean Hu, executive vice president, chief financial officer and treasurer, will present at Barclay’s 2025 Global Technology Conference on Wednesday, Dec. 10, 2025.Interested parties are invited to listen to the live webcasts and replays via the AMD Investor Relations website ir.amd.com. About AMD For more than 55 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions...

Continue reading

ZenaTech’s ZenaDrone Subsidiary to Conduct Meetings with Members of Congress Highlighting its Drone Innovation Followed by Showcasing Drone Solutions at the AUVSI Defense Forum

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, announces its US drone subsidiary ZenaDrone will be in Washington, D.C. later this month for company representatives to meet with key Members of Congress and other stakeholders to discuss the company’s drone innovation and US manufacturing plans. This will be followed by participating and showcasing ZenaDrone’s drone solutions at the Washington, D.C. AUVSI Defense 2025 Forum. “Our ZenaDrone subsidiary is committed to becoming a trusted supplier of drone solutions to US defense agencies and NATO. Through Capitol Hill engagement...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.